罗欣药业集团股份有限公司关于控股股东新增注册资本暨股权结构变动的进展公告

Group 1 - The core point of the announcement is the completion of the capital increase and shareholding structure change of the controlling shareholder, Shandong Luoxin Holdings Co., Ltd., which increased its registered capital from 200 million RMB to 252 million RMB through an investment of 130 million RMB by the Linyi Luozhuang District New and Old Kinetic Energy Conversion Fund Investment Co., Ltd. [2][3] - The capital increase will not affect the number of shares or the shareholding ratio held by the controlling shareholder, nor will it change the company's governance structure or management team [2][3] - The business scope of Luoxin Holdings includes investment management and consulting, excluding financial, securities, futures, insurance, guarantee, and financing businesses [3] Group 2 - The company has implemented an employee stock ownership plan (ESOP) for 2024, which involves repurchasing shares to allocate to employees [5][6] - The total amount for the share repurchase is between 50 million RMB and 100 million RMB, with a maximum repurchase price of 7.62 RMB per share [5] - As of February 8, 2024, the company has repurchased 26,027,861 shares, accounting for 2.39% of the total share capital, with a total transaction amount of approximately 99.99 million RMB [5][6] - The ESOP allows for a maximum of 26,027,861 shares, with 18,219,503 shares granted initially at a price of 2.03 RMB per share, and a reserved portion of 7,808,358 shares at a price of 2.63 RMB per share [6][10] - The ESOP is structured to ensure that no single employee can hold more than 1% of the total share capital through the plan [11]